Effects of dioxin and nutrition on cellular prolif era ti on and dioxin- and estrogen-linked genes in ovarian cancer cell lines

This study was undertaken to examine the effects of dioxin (TCDD) and nutrition on cellular proliferation and dioxin- and estrogen-linked gene expression in ovarian cancer cell lines. Caov-3 and SK-OV-3 cells were incubated in a medium supplemented with 0.5-10% fetal bovine serum (FBS). Cell proliferation was assayed with an MTT assay. Dioxin- and estrogen-linked genes (AhR, ERalpha, ERbeta, CYP1A1 and ARNT) expressed were determined with the RT-PCR method. Caov-3 cells, but not SK-OV-3 cells, were proliferated with TCDD alone with increased AhR and ERa mRNA expressions when incubated in the low FBS concentration. CYP1A1 and ARNT mRNA expressions of SK-OV-3, but not that of Caov-3, were suppressed in the low FBS (under 1.0%) concentration. In the low FBS concentration medium with dioxin, AhR and ERa expression were increased with the proliferation of Caov-3 cells; CYP1A1 and ARNT were stable. Each ovarian cancer cell line may have its own distinct responsiveness to dioxin depending on the nutritional state.

Dioxin; Aryl hydrocarbon receptor; Estrogen receptor; CYPIAI; Fetal bovine serum

[1] Rier S.E., Martin D.C., Bowman R.E., Dmowski W.P., Becker J.L.: "Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin" Fundam. Appl. Toxicol., 1993, 21, 433.

[2] Mayani A., Barel S., Soback S., Almagor M.: "Dioxin concentralions in women with endometriosis". Hum. Reprod., 1997, 12, 373.

[3] Safe S., Wormke M., Samudio I.: "Mechanisms of inhibitory arylhydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells". J. Mammary Gland Biol. Neoplasia, 2000, 5, 295.

[4] Nelson D.R., Koymans L., Kamataki T., Stegeman J.J., Feyereisen R., Waxman D.J. et al.: "P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature". Pharmacogenetics, 1996, 6, 1.

[5] Spink D.C., Lincoln D.W. 2nd., Dickerman H.W., Gierthy J.F "2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17 beta-estradiol metabolism in MCF-7 breast tumor cells". Proc. Natl. Acad. Sci.US A, 1990, 87, 6917.

[6] Spink D.C., Katz B.H., Hussain M.M., Pentecost B.T., Cao Z., Spink B.C.: "Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells". Carcinogenesis, 2003, 24, 1941.

[7] Rogers J.M., Denison M.S.: "Analysis of the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human ovarian carcinoma BG-I cells". Mo!. Pharmacol., 2002, 61, 1393.

[8] Chomczynski P., Sacchi N.: "Single-step method of RNA isolation by acid guanidium thiocyanate-chloroform extraction". Anal. Biochem, 1987, 162, 156.

[9] Misao R., Itoh N., Mori H., Fujimoto J., Tamaya T.: "Sex hormone-binding globulin mRNA levels in human uterine endometrium". Eur. J. Endocrinol., 1994, 131, 623.

[10] Toneguzzo F., Glynn S., Levi E., Mjolseness S., Hayday A.: "Use of a chemically modified T7 DNA polymerase for manual and automated sequencing of supercoiled DNA". Biotechniques, 1988, 6, 460.

[11] Williams S.R., Son D.S.. Terranova P.F.: "Protein kinase C delta is activated in mouse ovarian surface epithelial cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)". Toxicology, 2004, 195, I.

[12] Spink B.C., Fasco M.J., Gierthy J.F., Spink D.C.: "12-0-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP!Bl and CYP!A l expression in MCF-7 breast cancer cells". J. Cell. Biochem., 1998, 70, 289.

[13] Wolff S., Harper P.A., Wong J.M., Mo、tert V., Wang Y., Abel J "Cell-specific regulation of human aryl hydrocarbon receptor expression by transforming growth factor-beta(1)". Mol. Pharmacol., 2001, 59, 716.

[14] Vaziri C., Schneider A., Sherr D.H., Faller D.V.: "Expression of the aryl hydrocarbon receptor is regulated by serum and mitogenic growth factors in murine 3T3 fibroblasts". J. Biol. Chem., 1996, 271, 25921.

[15] Trombino A.F., Near R.I., Matulka R.A., Yang S., Hafer L.J., Toselli P.A. et al.: "Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYPI gene transcripts in a rat model of mammary tumorigenesis". Breast. Cancer Res. Treat., 2000, 63, 117.

[16] Khorram 0., Garthwaite M., Golos T.: "Uterine and ovarian aryl hydrocarbon receptor (AHR) and aryl hydrocarbon receptor nuclear translocator (ARNT) mRNA expression in benign and malignant gynaecological conditions". Mol. Hum. Reprod., 2002, 8, 75.

[17] Thomsen J.S., Wang X., Hines R.N., Safe S.: "Restoration of arylhydrocarbon (Ah) responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor". Carcinogenesis, 1994, 15, 933.

[18] Spink D.C., Spink B.C., Cao J.Q., DePasquale J.A., P entecost B.T., Pasco M.J. et al.: "Differential expression of CYPIA l and CYPlBI in human breast epithelial cells and breast tumor cells". Carcinogenesis, 1998, 19, 291.

[19] Angus W.G., Larsen M.C., Jefcoate C.R.: "Expression of CYP l Al and CYP l B 1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status". Carcinogenesis, 1999, 20, 947.

[20] V ickers P.J., Dufresne M.J., Cowan K.H.: "Relation between cytochrome P450IA1 expression and estrogen receptor content of human breast cancer cells". Mol. Endocrinol., 1989, 3, 157.

[21] Holcomb M., Safe S.: "Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin". Cancer Lett., 1994, 82, 43.

[22] Jana N.R., Sarkar S., Ishizuka M., Yonemoto J., Tohyama C., Sone H.: "Role of estradiol receptor-alpha in differential expression of 2,3,7, 8-tetrachlorodibenzo-p-dioxin-inducible genes in the RL95- 2 and KLE human endometrial cancer cell lines". Arch. Biochem. Biophys., 1999, 368, 31.

[23] Gierthy J.P., Lincoln D.W., Gillespie M.B., Seeger J.I., Martinez H.L., Dickerman H.W. et al.: "Suppression of estrogen-regulated extracellular tissue plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin". Cancer Res., 1987, 47, 6198.

[24] Spink D.C., Eugster H.P., Lincoln D.W, 2nd., Schuetz J.D., Schuetz E.G., Johnson J.A. et al.: "17 beta-estradiol hydroxylation catalyzed by human cytochrome P 450 !Al: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA". Arch. Biochem. Biophys., 1992, 293, 342.

[25] Hayes C.L., Spink D.C., Spink B.C., Cao J.Q., Walker N.J., Sutter T.R.: "17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 lBI". Proc. Natl. Acad. Sci. U S A, 1996, 93, 9776.

[26] Newbold R.R., Liehr J.G.: "Induction of uterine adenocarcinoma in CD-I mice by catechol estrogens". Cancer Res., 2000, 60, 235.

[27] Devanesan P., Todorovic R., Zhao J., Gross M.L., Rogan E.G., Cavalieri E.L.: "Catechol estrogen conjugates and DNA adducts in the kidney of male Syrian golden hamsters treated with 4-hydroxyestradiol: potential biomarkers for estrogen-initiated cancer". Carcinogenesis, 2001, 22, 489.

[28] Liehr J.G., Ricci M.J.: "4-Hydroxylation of estrogens as marker of human mammary tumors". Proc. Natl. Acad. Sci. US A, 1996, 93, 3294.

[29] Yager J.D.: "Endogenous estrogens as carcinogens through metabolic activation". J. Natl. Cancer Inst. Monogr., 2000, 67.

[30] Gu Y.Z., Hogenesch J.B., Bradfield C.A.: "The PAS superfamily: sensors of environmental and developmental signals". Annu. Rev. Pharmacol. Toxicol., 2000, 40, 519.

[31] FitzGerald C.T., Fernandez-Salguero P., Gonzalez F.J., Nebert D.W., Puga A.: "Differential regulation of mouse Ah receptor gene expression in cell lines of different tissue origins". Arch. Biochem. Biophys., 1996, 333, 170.

[32] Garrison P.M., Rogers J.M., Brackney W.R., Denison M.S.: "Effects of histone deacetylase inhibitors on the Ah receptor gene promoter". Arch. Biochem. Biophys., 2000, 374, 161.